Bronchiolitis Obliterans Syndrome Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: B9EFB335862AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Bronchiolitis Obliterans Syndrome in Global, including the following market information:

Global Bronchiolitis Obliterans Syndrome Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Bronchiolitis Obliterans Syndrome market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bronchiolitis Obliterans Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bronchiolitis Obliterans Syndrome Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Bronchiolitis Obliterans Syndrome Market Segment Percentages, By Type, 2020 (%)

• Inhalation
• Oral

China Bronchiolitis Obliterans Syndrome Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Bronchiolitis Obliterans Syndrome Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global Bronchiolitis Obliterans Syndrome Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Bronchiolitis Obliterans Syndrome Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Bronchiolitis Obliterans Syndrome Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Bronchiolitis Obliterans Syndrome Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Breath Therapeutics
• Genentech
• Incyte Corporation
• Mereo BioPharma
• Altavant Sciences
• Koutif Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 ACTH and GH Function Tests Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global ACTH and GH Function Tests Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ACTH AND GH FUNCTION TESTS OVERALL MARKET SIZE

2.1 Global ACTH and GH Function Tests Market Size: 2021 VS 2027
2.2 Global ACTH and GH Function Tests Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top ACTH and GH Function Tests Players in Global Market
3.2 Top Global ACTH and GH Function Tests Companies Ranked by Revenue
3.3 Global ACTH and GH Function Tests Revenue by Companies
3.4 Top 3 and Top 5 ACTH and GH Function Tests Companies in Global Market, by Revenue in 2020
3.5 Global Companies ACTH and GH Function Tests Product Type
3.6 Tier 1, Tier 2 and Tier 3 ACTH and GH Function Tests Players in Global Market
  3.6.1 List of Global Tier 1 ACTH and GH Function Tests Companies
  3.6.2 List of Global Tier 2 and Tier 3 ACTH and GH Function Tests Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global ACTH and GH Function Tests Market Size Markets, 2021 & 2027
  4.1.2 Blood
  4.1.3 Urine
  4.1.4 Others
4.2 By Type - Global ACTH and GH Function Tests Revenue & Forecasts
  4.2.1 By Type - Global ACTH and GH Function Tests Revenue, 2016-2021
  4.2.2 By Type - Global ACTH and GH Function Tests Revenue, 2022-2027
  4.2.3 By Type - Global ACTH and GH Function Tests Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global ACTH and GH Function Tests Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Diagnostic Laboratories
  5.1.4 Ambulatory Surgical Centers
  5.1.5 Other Home Care Settings
5.2 By Application - Global ACTH and GH Function Tests Revenue & Forecasts
  5.2.1 By Application - Global ACTH and GH Function Tests Revenue, 2016-2021
  5.2.2 By Application - Global ACTH and GH Function Tests Revenue, 2022-2027
  5.2.3 By Application - Global ACTH and GH Function Tests Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global ACTH and GH Function Tests Market Size, 2021 & 2027
6.2 By Region - Global ACTH and GH Function Tests Revenue & Forecasts
  6.2.1 By Region - Global ACTH and GH Function Tests Revenue, 2016-2021
  6.2.2 By Region - Global ACTH and GH Function Tests Revenue, 2022-2027
  6.2.3 By Region - Global ACTH and GH Function Tests Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America ACTH and GH Function Tests Revenue, 2016-2027
  6.3.2 US ACTH and GH Function Tests Market Size, 2016-2027
  6.3.3 Canada ACTH and GH Function Tests Market Size, 2016-2027
  6.3.4 Mexico ACTH and GH Function Tests Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe ACTH and GH Function Tests Revenue, 2016-2027
  6.4.2 Germany ACTH and GH Function Tests Market Size, 2016-2027
  6.4.3 France ACTH and GH Function Tests Market Size, 2016-2027
  6.4.4 U.K. ACTH and GH Function Tests Market Size, 2016-2027
  6.4.5 Italy ACTH and GH Function Tests Market Size, 2016-2027
  6.4.6 Russia ACTH and GH Function Tests Market Size, 2016-2027
  6.4.7 Nordic Countries ACTH and GH Function Tests Market Size, 2016-2027
  6.4.8 Benelux ACTH and GH Function Tests Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia ACTH and GH Function Tests Revenue, 2016-2027
  6.5.2 China ACTH and GH Function Tests Market Size, 2016-2027
  6.5.3 Japan ACTH and GH Function Tests Market Size, 2016-2027
  6.5.4 South Korea ACTH and GH Function Tests Market Size, 2016-2027
  6.5.5 Southeast Asia ACTH and GH Function Tests Market Size, 2016-2027
  6.5.6 India ACTH and GH Function Tests Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America ACTH and GH Function Tests Revenue, 2016-2027
  6.6.2 Brazil ACTH and GH Function Tests Market Size, 2016-2027
  6.6.3 Argentina ACTH and GH Function Tests Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa ACTH and GH Function Tests Revenue, 2016-2027
  6.7.2 Turkey ACTH and GH Function Tests Market Size, 2016-2027
  6.7.3 Israel ACTH and GH Function Tests Market Size, 2016-2027
  6.7.4 Saudi Arabia ACTH and GH Function Tests Market Size, 2016-2027
  6.7.5 UAE ACTH and GH Function Tests Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 GenWay Biotech
  7.1.1 GenWay Biotech Corporate Summary
  7.1.2 GenWay Biotech Business Overview
  7.1.3 GenWay Biotech ACTH and GH Function Tests Major Product Offerings
  7.1.4 GenWay Biotech ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.1.5 GenWay Biotech Key News
7.2 LifeSpan BioSciences
  7.2.1 LifeSpan BioSciences Corporate Summary
  7.2.2 LifeSpan BioSciences Business Overview
  7.2.3 LifeSpan BioSciences ACTH and GH Function Tests Major Product Offerings
  7.2.4 LifeSpan BioSciences ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.2.5 LifeSpan BioSciences Key News
7.3 Abcam plc
  7.3.1 Abcam plc Corporate Summary
  7.3.2 Abcam plc Business Overview
  7.3.3 Abcam plc ACTH and GH Function Tests Major Product Offerings
  7.3.4 Abcam plc ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.3.5 Abcam plc Key News
7.4 F. Hoffmann-La Roche Ltd
  7.4.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.4.2 F. Hoffmann-La Roche Ltd Business Overview
  7.4.3 F. Hoffmann-La Roche Ltd ACTH and GH Function Tests Major Product Offerings
  7.4.4 F. Hoffmann-La Roche Ltd ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.4.5 F. Hoffmann-La Roche Ltd Key News
7.5 Abbott laboratories
  7.5.1 Abbott laboratories Corporate Summary
  7.5.2 Abbott laboratories Business Overview
  7.5.3 Abbott laboratories ACTH and GH Function Tests Major Product Offerings
  7.5.4 Abbott laboratories ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.5.5 Abbott laboratories Key News
7.6 Laboratory Corporation of America
  7.6.1 Laboratory Corporation of America Corporate Summary
  7.6.2 Laboratory Corporation of America Business Overview
  7.6.3 Laboratory Corporation of America ACTH and GH Function Tests Major Product Offerings
  7.6.4 Laboratory Corporation of America ACTH and GH Function Tests Revenue in Global (2016-2021)
  7.6.5 Laboratory Corporation of America Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bronchiolitis Obliterans Syndrome Market Opportunities & Trends in Global Market
Table 2. Bronchiolitis Obliterans Syndrome Market Drivers in Global Market
Table 3. Bronchiolitis Obliterans Syndrome Market Restraints in Global Market
Table 4. Key Players of Bronchiolitis Obliterans Syndrome in Global Market
Table 5. Top Bronchiolitis Obliterans Syndrome Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Bronchiolitis Obliterans Syndrome Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Bronchiolitis Obliterans Syndrome Revenue Share by Companies, 2016-2021
Table 8. Global Companies Bronchiolitis Obliterans Syndrome Product Type
Table 9. List of Global Tier 1 Bronchiolitis Obliterans Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bronchiolitis Obliterans Syndrome Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Bronchiolitis Obliterans Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Bronchiolitis Obliterans Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Bronchiolitis Obliterans Syndrome Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Bronchiolitis Obliterans Syndrome Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2022-2027
Table 30. Breath Therapeutics Corporate Summary
Table 31. Breath Therapeutics Bronchiolitis Obliterans Syndrome Product Offerings
Table 32. Breath Therapeutics Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)
Table 33. Genentech Corporate Summary
Table 34. Genentech Bronchiolitis Obliterans Syndrome Product Offerings
Table 35. Genentech Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)
Table 36. Incyte Corporation Corporate Summary
Table 37. Incyte Corporation Bronchiolitis Obliterans Syndrome Product Offerings
Table 38. Incyte Corporation Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)
Table 39. Mereo BioPharma Corporate Summary
Table 40. Mereo BioPharma Bronchiolitis Obliterans Syndrome Product Offerings
Table 41. Mereo BioPharma Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)
Table 42. Altavant Sciences Corporate Summary
Table 43. Altavant Sciences Bronchiolitis Obliterans Syndrome Product Offerings
Table 44. Altavant Sciences Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)
Table 45. Koutif Therapeutics Corporate Summary
Table 46. Koutif Therapeutics Bronchiolitis Obliterans Syndrome Product Offerings
Table 47. Koutif Therapeutics Bronchiolitis Obliterans Syndrome Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Bronchiolitis Obliterans Syndrome Segment by Type
Figure 2. Bronchiolitis Obliterans Syndrome Segment by Application
Figure 3. Global Bronchiolitis Obliterans Syndrome Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Bronchiolitis Obliterans Syndrome Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Bronchiolitis Obliterans Syndrome Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bronchiolitis Obliterans Syndrome Revenue in 2020
Figure 8. By Type - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 9. By Application - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 10. By Region - Global Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 11. By Country - North America Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 12. US Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 16. Germany Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 17. France Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 24. China Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 28. India Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 30. Brazil Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Bronchiolitis Obliterans Syndrome Revenue Market Share, 2016-2027
Figure 33. Turkey Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Bronchiolitis Obliterans Syndrome Revenue, (US$, Mn), 2016-2027
Figure 37. Breath Therapeutics Bronchiolitis Obliterans Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Genentech Bronchiolitis Obliterans Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Incyte Corporation Bronchiolitis Obliterans Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Mereo BioPharma Bronchiolitis Obliterans Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Altavant Sciences Bronchiolitis Obliterans Syndrome Revenue Year Over Year Growth (US$, Mn) & (2016-2021)